Clinical Trials on Anemia, Hemolytic, Autoimmune in Switzerland

Total 446 results

Hoffmann-La Roche

Completed

MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia

Anemia

Austria, Switzerland
University Hospital, Geneva
University of Geneva, Switzerland

Recruiting

Anhydroglucitol in Children With Type 1 Diabetes

Diabetes Mellitus, Type 1

Switzerland
University Hospital Inselspital, Berne
University of Bern

Completed

Full Mouth Disinfection and Antibiotics for Periodontitis in High or Moderate Disease Activity Rheumatoid Arthritis (FMD-ABRA)

Rheumatoid Arthritis

Switzerland
University Hospital, Basel, Switzerland
University Hospital, Geneva; University of Lausanne Hospitals; National Multiple... and other collaborators

Recruiting

Swiss Multiple Sclerosis Cohort-Study (SMSC)

Multiple Sclerosis

Switzerland
Fondazione Epatocentro Ticino

Recruiting

Swiss Autoimmune Hepatitis Cohort Study

Hepatitis, Autoimmune

Switzerland
University Hospital Inselspital, Berne

Completed

Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes (DE-CAF)

Placebo | Caffeine and Carbohydrate | Carbohydrate Only

Switzerland
University Hospital Inselspital, Berne
Baxter Healthcare Corporation

Completed

Hemodialysis Frequency and the Calcification Propensity of Serum (Intensified HD)

Hemodialysis | Anuria

Switzerland
University Hospital Inselspital, Berne
University of Lausanne; University of Bern

Completed

Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes (CARBEX1)

Hypoglycemia | Exercise | Type 1 Diabetes Mellitus | Carbohydrate Metabolism

Switzerland
Lia Bally
University of Zurich

Completed

Simplified Meal Approach Using Hybrid Closed-loop Insulin Delivery in Youth and Young Adults With Type 1 Diabetes (SMASH)

Type 1 Diabetes

Switzerland
XOMA (US) LLC
Juvenile Diabetes Research Foundation

Completed

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

Type 1 Diabetes

Switzerland
Lia Bally

Active, not recruiting

Supporting Meal Management in Type 1 Diabetes (SUMMIT1)

Type 1 Diabetes

Switzerland
University Hospital Inselspital, Berne

Completed

Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec (FruDeg)

Diabetes Complications | Type 1 Diabetes Mellitus

Switzerland
Rüdiger B. Müller
UCB Pharma

Completed

RICE: Remission by Intra-articular Injection Plus CErtolizumab (RICE)

Rheumatoid Arthritis

Switzerland
Wellspect HealthCare
Wellspect HealthCare

Recruiting

Comparing Transanal Irrigation With Navina Smart vs. Standard Bowel Care in Patients With Multiple Sclerosis

Multiple Sclerosis | Fecal Incontinence | Neurogenic Bowel (Disorder) | Fecal Constipation

Denmark, Switzerland, United Kingdom, France, Spain
Ypsomed AG
Diabetes Center Berne Research AG

Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Diabetes Mellitus, Type 1

Germany, Switzerland
Fundación Pública Andaluza Progreso y Salud
Karolinska Institutet; Eli Lilly and Company; Medical University of Vienna; Sanofi and other collaborators

Completed

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: (PRECISESADS)

Systemic Autoimmune Diseases

France, Germany, Austria, Portugal, Hungary, Belgium, Italy, Spain, Switzerland
University Hospital, Basel, Switzerland
Swiss Multiple Sclerosis Registry

Recruiting

A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort. (MS COVID-19)

Multiple Sclerosis | COVID-19 (Severe Coronavirus Disease 2019)

Switzerland
Doctor Giacomo Gastaldi
University Hospital, Geneva

Unknown

Influence of Diabetic Neuropathy on Activation of Brown Adipose Tissue (DIA-BAT)

Diabetes Mellitus, Type 1

Switzerland
University of Zurich

Unknown

Rituximab-induced Pulmonary Function Changes

Rheumatoid Arthritis | Inflammatory Myositis

Switzerland
Bayer

Completed

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon

Multiple Sclerosis, Relapsing Remitting

Belgium, Bosnia and Herzegovina, Italy, Austria, Croatia, Czechia, France, Greece, Hungary, Spain, Switzerland
Hospices Civils de Lyon

Unknown

CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors

Churg-Strauss Syndrome

Switzerland
University Hospital, Basel, Switzerland

Terminated

CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography

Coronary Artery Disease | Lupus Erythematosus, Systemic | Myocardial Disease

Switzerland
University of Lausanne Hospitals

Completed

Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial

Diabetes | Rheumatoid Arthritis

Switzerland
Bayer

Completed

BENEFIT Extension Study

Multiple Sclerosis

Switzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
Hoffmann-La Roche
PPD; Laboratory Corporation of America; Illingworth Research Group

Active, not recruiting

A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy (MINORE)

Multiple Sclerosis | Clinically Isolated Syndrome

United States, Spain, Switzerland, France, Germany
Spiden AG
DCB Research AG

Completed

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With Hyperglycemia

Switzerland
Ospedale San Raffaele
Juvenile Diabetes Research Foundation

Completed

Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation (ECIT-1)

Type 1 Diabetes

Italy, Switzerland
Philippe Klee

Completed

Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes

Quality of Life | Type 1 Diabetes | Hypoglycaemia

Switzerland
Pediatric Clinical Research Platform
University Hospital, Geneva; University of Geneva, Switzerland

Recruiting

Mechanisms of Type 1 Diabetes Endophenotypes (METYDIA)

Genetic Predisposition to Disease | Type 1 Diabetes Mellitus

Switzerland
Biogen

Completed

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen (SFERA)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)

Czech Republic, Switzerland
Vista Klinik
University Hospital, Basel, Switzerland

Completed

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

Insulin-Dependent Diabetes Mellitus 1

Switzerland
Hospices Civils de Lyon

Unknown

CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors

Microscopic Polyangiitis | Polyarteritis Nodosa

Switzerland
Onconova Therapeutics, Inc.

Terminated

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE)

Myelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEB

United States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
Biogen

Completed

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Relapsing-remitting Multiple Sclerosis

Belgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
Christian Meier
University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland and other collaborators

Completed

Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes (BOLD-1)

Type 1 Diabetes Mellitus

Switzerland
Centre Hospitalier Universitaire de Nice
Genzyme, a Sanofi Company

Completed

Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome (TERIS)

Multiple Sclerosis

Turkey, France, Switzerland
Vista Klinik
University Hospital, Zürich

Completed

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

Insulin-Dependent Diabetes Mellitus 1

Switzerland
University Hospital, Basel, Switzerland
Swiss National Science Foundation; Kantonsspital Baselland Bruderholz; HEMMI...

Recruiting

Taper Or Abrupt Steroid Stop: TOASSTtrial (TOASST)

Autoimmune | Inflammatory Disorder

Germany, Switzerland
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

Rheumatoid Arthritis | Ankylosing Spondylitis

Switzerland
Novartis Pharmaceuticals

Recruiting

Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study (KOSMOS)

Multiple Sclerosis

Switzerland
University of Bern
Novartis; University Hospital Inselspital, Berne; Schweizerische Multiple Sklerose... and other collaborators

Recruiting

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Multiple Sclerosis | Optic Neuritis | Neuromyelitis Optica Spectrum Disorder | CNS Sarcoidosis | CNS Vasculitis | Transverse Myelitis | Rasmussen Encephalitis | Acute Disseminated Encephalomyelitis | Anti-NMDAR Encephalitis | Anti-GAD65 Associated Autoimmune Encephalitis | Anti-AMPAR-1/2 Associated Autoimmune... and other conditions

Switzerland
University Hospital Freiburg

Completed

Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment

Myelodysplastic Syndromes | Fanconi Anemia | Dyskeratosis Congenita | Pearson Marrow-pancreas Syndrome | Shwachman-diamond Syndrome

Spain, Germany, Switzerland, Austria, Netherlands, Italy, Czech Republic, Belgium, Denmark, Ireland
Amgen

Completed

TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin Beta (TRANSFORM)

Anemia

Belgium, France, Netherlands, Greece, Spain, Germany, Switzerland
University of Lausanne Hospitals

Completed

Isometric Handgrip Exercise -MRI in Children and Adolescents

Coronary Artery Disease | Type 1 Diabetes Mellitus

Switzerland
Genzyme, a Sanofi Company

Terminated

LEMTRADA Pregnancy Registry in Multiple Sclerosis

Multiple Sclerosis

United States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
Novartis

Completed

Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation, Spain, Turkey, Switzerland
Sandoz
Hexal AG

Completed

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5 (MONITOR-CKD5)

Chronic Kidney Disease | End-stage Renal Disease | Anaemia

Austria, France, Germany, Italy, Poland, Romania, Slovenia, Spain, Switzerland, United Kingdom
University of Zurich

Recruiting

Exophthalmometry With 3D Face Scanners (EX3D)

Graves Ophthalmopathy | Exophthalmos | Orbital Fractures | Orbital Tumor

Switzerland
Fundación Pública Andaluza Progreso y Salud
Karolinska Institutet; Eli Lilly and Company; Medical University of Vienna; Sanofi and other collaborators

Completed

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control (PRECISESADST)

Healthy Subjects

France, Austria, Germany, Portugal, Hungary, Belgium, Italy, Spain, Switzerland
University of Cambridge
Medical University of Graz; University Hospital Inselspital, Berne; Manchester...

Completed

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_P3)

Type 1 Diabetes

United Kingdom, Austria, Switzerland

Clinical Trials on Anemia, Hemolytic, Autoimmune in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations